信息编号11329501至11330000间共499条。 >>更多

• 11329501:Phase II Trial of Postoperative Adjuvant Paclitaxel/Carboplatin and Thoracic Radiotherapy in Resected Stage II and IIIA Non–Small-Cell Lung
• 11329502:《中医基础理论》教学过程中培养中医思维方法刍议
• 11329503:Clinical Examination Following Preoperative Chemoradiation for Rectal Cancer Is Not a Reliable Surrogate End Point
• 11329504:Phase I Study of Hepatic Arterial Melphalan Infusion and Hepatic Venous Hemofiltration Using Percutaneously Placed Catheters in Patients Wit
• 11329505:Randomized Comparison of Group Versus Individual Genetic Education and Counseling for Familial Breast and/or Ovarian Cancer
• 11329506:Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of Relapse
• 11329507:颈髓肠源性囊肿1例
• 11329508:宫腔粘连合并早孕1例
• 11329509:Ablative Allogeneic Hematopoietic Cell Transplantation in Adults 60 Years of Age and Older
• 11329510:Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of Unmutated VH Gene in Patients With Chronic Lymphocytic Leukemia
• 11329511:Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma Modulates Intratumoral CD4/CD8 Ratio and Tumor Microenvironment: A Multicenter Pha
• 11329512:Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies
• 11329513:International Staging System for Multiple Myeloma
• 11329514:Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharma
• 11329515:The Cutaneous B-Cell Lymphoma Prognostic Index: A Novel Prognostic Index Derived From a Population-Based Registry
• 11329516:Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Ly
• 11329517:Phase II Study of Nelarabine(compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’
• 11329518:Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression
• 11329519:Short-Course Versus Split-Course Radiotherapy in Metastatic Spinal Cord Compression: Results of a Phase III, Randomized, Multicenter Trial
• 11329520:Effect of Docetaxel in Patients With Hormone-Dependent Prostate-Specific Antigen Progression After Local Therapy for Prostate Cancer
• 11329521:Multicenter Randomized Phase II Study of Two Schedules of Docetaxel, Estramustine, and Prednisone Versus Mitoxantrone Plus Prednisone in Pat
• 11329522:Changes in Gene Expression Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer
• 11329523:Quality of Life Among Younger Women With Breast Cancer
• 11329524:Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer
• 11329525:Mapping Molecular Networks Using Proteomics: A Vision for Patient-Tailored Combination Therapy
• 11329526:Clinicopathologic Behavior of Gastric Adenocarcinoma in Hispanic Patients: Analysis of a Single Institution's Experience Over 15 Years
• 11329527:Randomized Trial of Hyperthermia and Radiation for Superficial Tumors
• 11329528:Catalytic Subunit of Human Telomerase Reverse Transcriptase Is an Independent Predictor of Survival in Patients Undergoing Curative Resectio
• 11329529:TGFBR16A May Contribute to Hereditary Colorectal Cancer
• 11329530:Evaluation of Epothilone B Analog in Advanced Soft Tissue Sarcoma: A Phase II Study of the Phase II Consortium
• 11329531:Side Effects and Cancer-Related Stress Determine Quality of Life in Long-Term Survivors of Testicular Cancer
• 11329532:Depression, Correlates of Depression, and Receipt of Depression Care Among Low-Income Women With Breast or Gynecologic Cancer
• 11329533:Role of the CDKN2A Locus in Patients With Multiple Primary Melanomas
• 11329534:Expression of Interleukin-10 Splicing Variants Is a Positive Prognostic Feature in Relapsed Childhood Acute Lymphoblastic Leukemia
• 11329535:Increased Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose(FDG) Uptake in Childhood CNS Tumors Is Correlated With Malignancy Grade: A Study With FDG
• 11329536:Xerostomia Following Radiotherapy of the Head and Neck Affects Vocal Function
• 11329537:Central Venous Lines in Children With Lesser Risk Acute Lymphoblastic Leukemia: Optimal Type and Timing of Placement
• 11329538:Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial
• 11329539:Patterns and Correlates of Local Therapy for Women With Ductal Carcinoma-In-Situ
• 11329540:Mitotic Index and Benefit of Adjuvant Anthracycline-Based Chemotherapy in Patients With Early Breast Cancer
• 11329541:Phase III Randomized Trial of Doxorubicin and Docetaxel Versus Doxorubicin and Cyclophosphamide As Primary Medical Therapy in Women With Bre
• 11329542:Neoadjuvant Percutaneous 4-Hydroxytamoxifen Decreases Breast Tumoral Cell Proliferation: A Prospective Controlled Randomized Study Comparing
• 11329543:Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Surviv
• 11329544:Results of the Dutch National Study of the Palliative Effect of Irradiation Using Two Different Treatment Schemes for Non–Small-Cell Lung Ca
• 11329545:Clinically Meaningful Improvement in Symptoms and Quality of Life for Patients With Non-Small-Cell Lung Cancer Receiving Gefitinib in a Rand
• 11329546:Time From Treatment to Subsequent Diagnosis of Brain Metastases in Stage III Non–Small-Cell Lung Cancer: A Retrospective Review by the South
• 11329547:The Combined Percentage of Gleason Patterns 4 and 5 Is the Best Predictor of Cancer Progression After Radical Prostatectomy
• 11329548:Vinorelbine Plus Cisplatin Versus Docetaxel Plus Gemcitabine in Advanced Non-Small-Cell Lung Cancer: A Phase III Randomized Trial
• 11329549:Platinum-Based Versus Non-Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of the Published Literature
• 11329550:Natural History of Rising Serum Prostate-Specific Antigen in Men With Castrate Nonmetastatic Prostate Cancer
• 11329551:Capecitabine As First-Line Treatment for Patients Older Than 70 Years With Metastatic Colorectal Cancer: An Oncopaz Cooperative Group Study
• 11329552:Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-S
• 11329553:Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After
• 11329554:Diagnostic Performance of Nanoparticle-Enhanced Magnetic Resonance Imaging in the Diagnosis of Lymph Node Metastases in Patients With Endome
• 11329555:Phase I Study of BMS-214662, a Farnesyl Transferase Inhibitor in Patients With Acute Leukemias and High-Risk Myelodysplastic Syndromes
• 11329556:Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin
• 11329557:Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on Outcome
• 11329558:Docetaxel Followed by Hormone Therapy in Men Experiencing Increasing Prostate-Specific Antigen After Primary Local Treatments for Prostate C
• 11329559:Chemokine Receptor CXCR4 Expression in Colorectal Cancer Patients Increases the Risk for Recurrence and for Poor Survival
• 11329560:Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External R
• 11329561:Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience
• 11329562:Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
• 11329563:Familial Gastrointestinal Stromal Tumor Syndrome: Phenotypic and Molecular Features in a Kindred
• 11329564:Phase II Clinical Trial of Ixabepilone(BMS-247550), an Epothilone B Analog, in Metastatic and Locally Advanced Breast Cancer
• 11329565:Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer
• 11329566:Electrical Impedance Scanning for the Early Detection of Breast Cancer in Young Women: Preliminary Results of a Multicenter Prospective Clin
• 11329567:Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Proto
• 11329568:Epirubicin Increases Long-Term Survival in Adjuvant Chemotherapy of Patients With Poor-Prognosis, Node-Positive, Early Breast Cancer: 10-Yea
• 11329569:Doxorubicin With Cyclophosphamide Followed by Docetaxel Every 21 Days Compared With Doxorubicin and Docetaxel Every 14 Days As Preoperative
• 11329570:Risk Factors and Individual Probabilities of Melanoma for Whites
• 11329571:Pentostatin in Steroid-Refractory Acute Graft-Versus-Host Disease
• 11329572:Nationwide Survey on Complementary and Alternative Medicine in Cancer Patients in Japan
• 11329573:Infectious Complications of Central Venous Catheters Increase the Risk of Catheter-Related Thrombosis in Hematology Patients: A Prospective
• 11329575:Late Referrals to Specialized Palliative Care Service in Japan
• 11329576:Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia
• 11329577:Treatment of Nonmetastatic Rhabdomyosarcoma in Childhood and Adolescence: Third Study of the International Society of Paediatric Oncology—SI
• 11329578:Phase III, Randomized, Double-Blind Study of Epoetin Alfa Compared With Placebo in Anemic Patients Receiving Chemotherapy
• 11329579:Weekly Epoetin Alfa Maintains Hemoglobin, Improves Quality of Life, and Reduces Transfusion in Breast Cancer Patients Receiving Chemotherapy
• 11329580:COX-2: A Molecular Target for Colorectal Cancer Prevention
• 11329581:Phase I Pharmacokinetic and Pharmacodynamic Study of Weekly 1-Hour and 24-Hour Infusion BMS-214662, a Farnesyltransferase Inhibitor, in Pati
• 11329582:Phase I Clinical Study of Pertuzumab, a Novel HER Dimerization Inhibitor, in Patients With Advanced Cancer
• 11329583:Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epider
• 11329584:Effectiveness of Physical Activity on Cardiorespiratory Fitness and Health-Related Quality of Life in Young and Middle-Aged Cancer Patients
• 11329585:Randomized Phase II Study of Temozolomide and Radiotherapy Compared With Radiotherapy Alone in Newly Diagnosed Glioblastoma Multiforme
• 11329586:Effects of Parenteral Hydration in Terminally Ill Cancer Patients: A Preliminary Study
• 11329587:Extracapsular Extension of Pelvic Lymph Node Metastases From Urothelial Carcinoma of the Bladder Is an Independent Prognostic Factor
• 11329588:Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Me
• 11329589:Prognostic Role of Interleukin-1 Gene and Interleukin-1 Receptor Antagonist Gene Polymorphisms in Patients With Advanced Gastric Cancer
• 11329590:Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial
• 11329591:Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of
• 11329592:Low Microsatellite Instability Is Associated With Poor Prognosis in Stage C Colon Cancer
• 11329593:Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution
• 11329594:Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus
• 11329595:Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma
• 11329596:Risk of New Cancers After Radiotherapy in Long-Term Survivors of Retinoblastoma: An Extended Follow-Up
• 11329597:Serial Evaluation of Academic and Behavioral Outcome After Treatment With Cranial Radiation in Childhood
• 11329598:Prognostic Significance of Allelic Imbalance at the c-kit Gene Locus and c-kit Overexpression by Immunohistochemistry in Pediatric Osteosarc
• 11329599:Early Responses to Chemotherapy of Normal and Malignant Hematologic Cells Are Prognostic in Children With Acute Lymphoblastic Leukemia
• 11329600:Concurrent Administration of High-Dose Rituximab Before and After Autologous Stem-Cell Transplantation for Relapsed Aggressive B-Cell Non-Ho
• 11329601:Primary CNS Lymphoma of T-Cell Origin: A Descriptive Analysis From the International Primary CNS Lymphoma Collaborative Group
• 11329602:Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera
• 11329603:Meta-Analysis to Evaluate the Role of Interferon in Follicular Lymphoma
• 11329604:Increasing Incidence of Late Second Malignancies After Conditioning With Cyclophosphamide and Total-Body Irradiation and Autologous Bone Mar
• 11329605:Improving Accrual of Older Persons to Cancer Treatment Trials: A Randomized Trial Comparing an Educational Intervention With Standard Inform
• 11329606:Patients With an Unclassified Genetic Variant in the BRCA1 or BRCA2 Genes Show Different Clinical Features From Those With a Mutation
• 11329607:Postoperative Adjuvant Therapy With Tamoxifen, Tegafur Plus Uracil, or Both in Women With Node-Negative Breast Cancer: A Pooled Analysis of
• 11329608:Prospective, Randomized Comparison of High-Dose Chemotherapy With Stem-Cell Support Versus Intermediate-Dose Chemotherapy After Surgery and
• 11329609:Randomized Trial of Amifostine in Locally Advanced Non–Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiatio
• 11329610:Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule
• 11329611:Safety and Efficacy of Two Different Doses of Capecitabine in the Treatment of Advanced Breast Cancer in Older Women
• 11329612:Randomized Phase II Study of Two Gemcitabine Schedules for Patients With Impaired Performance Status(Karnofsky performance status 70) and
• 11329613:The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy
• 11329614:Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboemb
• 11329615:Study of Anxiety Disorder and Depression in Long-Term Survivors of Testicular Cancer
• 11329616:Attitudes of Patients With Incurable Cancer Toward Medical Treatment in the Last Phase of Life
• 11329617:Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Do
• 11329618:Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning
• 11329619:Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to
• 11329620:Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori The
• 11329621:Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse
• 11329622:Paclitaxel Decreases the Interstitial Fluid Pressure and Improves Oxygenation in Breast Cancers in Patients Treated With Neoadjuvant Chemoth
• 11329623:Pattern of Prostate-Specific Antigen(PSA) Failure Dictates the Probability of a Positive Bone Scan in Patients With an Increasing PSA After
• 11329624:Evolving Treatment Strategies for Inflammatory Breast Cancer: A Population-Based Survival Analysis
• 11329625:Sequencing of Chemotherapy and Radiation Therapy in Early-Stage Breast Cancer: Updated Results of a Prospective Randomized Trial
• 11329627:Implications of the Prostate Cancer Prevention Trial: A Decision Analysis Model of Survival Outcomes
• 11329628:EGR1 Predicts PTEN and Survival in Patients With Non–Small-Cell Lung Cancer
• 11329629:Risk Markers of Oral Cancer in Clinically Normal Mucosa As an Aid in Smoking Cessation Counseling
• 11329630:Clinical Characteristics of Pheochromocytoma Patients With Germline Mutations in SDHD
• 11329631:Psychological Impact of Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer
• 11329632:Trabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes Fails
• 11329633:Phase I and Pharmacologic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients With Solid Tumors
• 11329634:Impact of Short-Term Preoperative Radiotherapy on Health-Related Quality of Life and Sexual Functioning in Primary Rectal Cancer: Report of
• 11329635:Phase I Trial of the Cyclin-Dependent Kinase Inhibitor and Protein Kinase C Inhibitor 7-Hydroxystaurosporine in Combination With Fluorouraci
• 11329636:Randomized Trial of Two Intravenous Schedules of the Topoisomerase I Inhibitor Liposomal Lurtotecan in Women With Relapsed Epithelial Ovaria
• 11329637:Effectiveness of Gene Expression Profiling for Response Prediction of Rectal Adenocarcinomas to Preoperative Chemoradiotherapy
• 11329638:Phase III Southwest Oncology Group 9415/Intergroup 0153 Randomized Trial of Fluorouracil, Leucovorin, and Levamisole Versus Fluorouracil Con
• 11329640:Phase II Study of Radiotherapy Employing Proton Beam for Hepatocellular Carcinoma
• 11329641:Role of Transforming Growth Factor Beta in Human Cancer
• 11329642:Expression of the Caudal-Type Homeodomain Transcription Factors CDX 1/2 and Outcome in Carcinomas of the Ampulla of Vater
• 11329643:Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistoch
• 11329644:What Is Targeted Therapy
• 11329645:Moving Away From the "One Shoe Fits All" Strategy: The Key to Future Progress in Chemotherapy
• 11329646:Optimizing Endocrine Therapy for Breast Cancer
• 11329647:Radiation Therapy for Invasive Breast Cancer: Not Just for Local Control
• 11329648:Continuing Evolution in Breast Cancer Surgical Management
• 11329649:Integration of Imaging in the Management of Breast Cancer
• 11329650:Chemoprevention in the 21st Century: Is a Balance Best or Should Women Have No Estrogen at All
• 11329651:Pivotal Study of Iodine-131–Labeled Chimeric Tumor Necrosis Treatment Radioimmunotherapy in Patients With Advanced Lung Cancer
• 11329652:Prognostic and Predictive Factors for Breast Cancer: Translating Technology to Oncology
• 11329653:Health Care Provider-Directed Intervention to Increase Colorectal Cancer Screening Among Veterans: Results of a Randomized Controlled Trial
• 11329654:High Risk of Brain Metastases in Surgically Staged IIIA Non–Small-Cell Lung Cancer Patients Treated With Surgery, Chemotherapy, and Radiatio
• 11329655:Salvage Radiotherapy in Patients With Relapsed and Refractory Hodgkin’s Lymphoma: A Retrospective Analysis From the German Hodgkin Lymphoma
• 11329656:Common Polymorphism G(-248)A in the Promoter Region of the bax Gene Results in Significantly Shorter Survival in Patients With Chronic Lymph
• 11329657:Results of Whole-Brain Radiation As Salvage of Methotrexate Failure for Immunocompetent Patients With Primary CNS Lymphoma
• 11329658:Rituximab Plus Short-Duration Chemotherapy As First-Line Treatment for Follicular Non-Hodgkin’s Lymphoma: A Phase II Trial of the Minnie Pea
• 11329659:Atypical Teratoid/Rhabdoid Tumors(ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkyla
• 11329660:Prognostic Significance of Activated Akt Expression in Melanoma: A Clinicopathologic Study of 292 Cases
• 11329661:TP53 Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter Study
• 11329662:Plasma Bikunin As a Favorable Prognostic Factor in Ovarian Cancer
• 11329663:Preoperative Serum Squamous Cell Carcinoma Antigen Levels in Clinical Decision Making for Patients With Early-Stage Cervical Cancer
• 11329664:Dietary Counseling Improves Patient Outcomes: A Prospective, Randomized, Controlled Trial in Colorectal Cancer Patients Undergoing Radiother
• 11329665:Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
• 11329666:Supradose Intra-Arterial Cisplatin and Concurrent Radiation Therapy for the Treatment of Stage IV Head and Neck Squamous Cell Carcinoma Is F
• 11329667:Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone(BMS-247550) With or Without Estramustine Phosphate in
• 11329668:Site of Primary Tumor Has a Prognostic Role in Operable Breast Cancer: The International Breast Cancer Study Group Experience
• 11329669:Postmastectomy Radiation and Mortality in Women With T1-2 Node-Positive Breast Cancer
• 11329670:Gemcitabine, Epirubicin, and Paclitaxel Versus Fluorouracil, Epirubicin, and Cyclophosphamide As First-Line Chemotherapy in Metastatic Breas
• 11329671:Size of Breast Cancer Metastases in Axillary Lymph Nodes: Clinical Relevance of Minimal Lymph Node Involvement
• 11329672:Weight, Weight Gain, and Survival After Breast Cancer Diagnosis
• 11329673:Phase I Trial of Capecitabine and Weekly Irinotecan in Combination With Radiotherapy for Neoadjuvant Therapy of Rectal Cancer
• 11329675:Predictors of Survival After Radiofrequency Thermal Ablation of Colorectal Cancer Metastases to the Liver: A Prospective Study
• 11329676:Intrathecal Mafosfamide: A Preclinical Pharmacology and Phase I Trial
• 11329677:Communicating With Realism and Hope: Incurable Cancer Patients' Views on the Disclosure of Prognosis
• 11329678:Should 5-Hydroxytryptamine-3 Receptor Antagonists Be Administered Beyond 24 Hours After Chemotherapy to Prevent Delayed Emesis Systematic Re
• 11329679:Psychoeducational Intervention for Patients With Cutaneous Malignant Melanoma: A Replication Study
• 11329680:Predictive Value of the Pretreatment Extent of Disease System in Hepatoblastoma: Results From the International Society of Pediatric Oncolog
• 11329681:Does a History of Childhood Sexual Abuse Affect Sexual Outcomes in Breast Cancer Survivors
• 11329682:Profile of Patients With Kaposi's Sarcoma in the Era of Highly Active Antiretroviral Therapy
• 11329683:Molecular Staging in Stage II and III Melanoma Patients and Its Effect on Long-Term Survival
• 11329684:Paclitaxel-Based Chemoradiotherapy in Localized Gastric Carcinoma: Degree of Pathologic Response and Not Clinical Parameters Dictated Patien
• 11329685:Selective Excision of Metastatic Brain Tumors Originating in the Motor Cortex With Preservation of Function
• 11329686:Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Federatio
• 11329687:Randomized Trial Comparing Iridium Implant Plus External-Beam Radiation Therapy With External-Beam Radiation Therapy Alone in Node-Negative
• 11329688:Randomized Trial of 30 Versus 20 Gy in the Adjuvant Treatment of Stage I Testicular Seminoma: A Report on Medical Research Council Trial TE1
• 11329689:First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Pl
• 11329690:Weekly Paclitaxel and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study
• 11329691:Patterns of Resistance and Incomplete Response to Docetaxel by Gene Expression Profiling in Breast Cancer Patients
• 11329692:Concurrent Hyperfractionated Radiotherapy and Low-Dose Daily Carboplatin and Paclitaxel in Patients With Stage III Non–Small-Cell Lung Cance
• 11329693:Clinical Role of Multidrug Resistance Protein 1 Expression in Chemotherapy Resistance in Early-Stage Breast Cancer: The Austrian Breast and
• 11329694:[18F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung Cancer
• 11329695:Analysis of Concerted Expression of Angiogenic Growth Factors in Acute Myeloid Leukemia: Expression of Angiopoietin-2 Represents an Independ
• 11329696:Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated
• 11329697:Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two
• 11329698:Phase II Trial of Individualized Rituximab Dosing for Patients With CD20-Positive Lymphoproliferative Disorders
• 11329699:Rituximab Therapy for Patients With Newly Diagnosed, Advanced-Stage, Follicular Grade I Non-Hodgkin's Lymphoma: A Phase II Trial in the Nort
• 11329700:Maximizing Therapeutic Benefit of Rituximab: Maintenance Therapy Versus Re-Treatment at Progression in Patients With Indolent Non-Hodgkin's
• 11329701:Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer
• 11329703:Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions
• 11329704:Randomized Pharmacokinetic and Pharmacodynamic Study of Docetaxel: Dosing Based on Body-Surface Area Compared With Individualized Dosing Bas
• 11329707:Blockade of Platelet-Derived Growth Factor Receptor-Beta by CDP860, a Humanized, PEGylated di-Fab', Leads to Fluid Accumulation and Is Assoc
• 11329708:Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in
• 11329709:Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma
• 11329710:Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of
• 11329711:Relationship Between MYCN Copy Number and Expression in Rhabdomyosarcomas and Correlation With Adverse Prognosis in the Alveolar Subtype
• 11329712:Lymphatic Vessel Invasion As a Prognostic Factor in Patients With Primary Resected Adenocarcinomas of the Esophagogastric Junction
• 11329713:Molecular and Clinical Analysis of Locally Advanced Dermatofibrosarcoma Protuberans Treated With Imatinib: Imatinib Target Exploration Conso
• 11329714:EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagno
• 11329715:Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer
• 11329716:Phase III Study of Matrix Metalloproteinase Inhibitor Prinomastat in Non–Small-Cell Lung Cancer
• 11329717:Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metasta
• 11329718:Outcome Predictors for the Increasing PSA State After Definitive External-Beam Radiotherapy for Prostate Cancer
• 11329719:Individualized Predictions of Disease Progression Following Radiation Therapy for Prostate Cancer
• 11329720:Evaluation of Tamoxifen and Anastrozole in the Prevention of Gynecomastia and Breast Pain Induced by Bicalutamide Monotherapy of Prostate Ca
• 11329721:Androgen Suppression Plus Radiation Versus Radiation Alone for Patients With Stage D1/Pathologic Node-Positive Adenocarcinoma of the Prostat
• 11329722:Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast
• 11329723:Breast Cancer Treatment Guidelines in Older Women
• 11329724:Changes in Body Fat and Weight After a Breast Cancer Diagnosis: Influence of Demographic, Prognostic, and Lifestyle Factors
• 11329725:Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM Alone and Sequentially With Vaccinia-CEA(6D)-TRICOM, With and Without G
• 11329727:Discussions Regarding Reproductive Health for Young Women With Breast Cancer Undergoing Chemotherapy
• 11329728:Relationship Between Time Interval From Primary Surgery to the Start of Taxane- Plus Platinum-Based Chemotherapy and Clinical Outcome of Pat
• 11329729:Effect of Single-Agent Rituximab Given at the Standard Schedule or As Prolonged Treatment in Patients With Mantle Cell Lymphoma: A Study of
• 11329730:Rituximab in Combination With Fludarabine Chemotherapy in Low-Grade or Follicular Lymphoma
• 11329731:Phenotypic Heterogeneity in Multiple Myeloma Families
• 11329732:Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell
• 11329733:Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
• 11329734:Phase I and Pharmacokinetic Study of Oral Irinotecan Given Once Daily for 5 Days Every 3 Weeks in Combination With Capecitabine in Patients
• 11329735:Proteasome Inhibition As a Novel Therapeutic Target in Human Cancer
• 11329736:American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women
• 11329737:Long-Term Health-Related Quality of Life, Growth, and Spiritual Well-Being After Hematopoietic Stem-Cell Transplantation
• 11329738:Quality-of-Life Assessment in the Symptom Management Trials of the National Cancer Institute-Supported Community Clinical Oncology Program
• 11329739:Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer(EORTC) Soft Tis
• 11329740:Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Con
• 11329742:Platinum-Etoposide Chemotherapy in Elderly Patients With Small-Cell Lung Cancer: Results of a Randomized Multicenter Phase II Study Assessin
• 11329743:Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group(COSS)
• 11329744:Ewing Sarcomas With p53 Mutation or p16/p14ARF Homozygous Deletion: A Highly Lethal Subset Associated With Poor Chemoresponse
• 11329745:Advanced-Stage Large-Cell Lymphoma in Children and Adolescents: Results of a Randomized Trial Incorporating Intermediate-Dose Methotrexate a
• 11329746:Results of Induction Chemotherapy in Children Older Than 1 Year With a Stage 4 Neuroblastoma Treated With the NB 97 French Society of Pediat
• 11329747:Prognostic Implications of Multiple Lymphatic Basin Drainage in Patients With Truncal Melanoma
• 11329748:Phase I Clinical Trial of Mafosfamide in Infants and Children Aged 3 Years or Younger With Newly Diagnosed Embryonal Tumors: A Pediatric Bra
• 11329749:Racial Differences in Surgical Evaluation, Treatment, and Outcome of Locoregional Esophageal Cancer: A Population-Based Analysis of Elderly
• 11329750:Intensive Systemic Chemotherapy Combined With Surgery for Metastatic Colorectal Cancer: Results of a Phase II Study
• 11329751:Docetaxel and Continuous-Infusion Fluorouracil Versus Epirubicin, Cisplatin, and Fluorouracil for Advanced Gastric Adenocarcinoma: A Randomi
• 11329752:Outcome of Induction and Postremission Therapy in Younger Adults With Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Gr
• 11329753:Role of Anti-Hepatitis C Virus(HCV) Treatment in HCV-Related, Low-Grade, B-Cell, Non-Hodgkin's Lymphoma: A Multicenter Italian Experience
• 11329754:Polymorphisms in Fc{gamma}RIIIA(CD16) Receptor Expression Are Associated With Clinical Response to Rituximab in Waldenstrm’s Macroglobuline
• 11329759:Phase I Trial of Iodine-131 Tositumomab With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Relapsed Non-Hodgkin's Lymp
• 11329760:Randomized Phase II Study of Two Doses of Gefitinib in Hormone-Refractory Prostate Cancer: A Trial of the National Cancer Institute of Canad
• 11329761:Downregulation of Smac/DIABLO Expression in Renal Cell Carcinoma and Its Prognostic Significance
• 11329762:Long-Term Survival Rates of Patients With Prostate Cancer in the Prostate-Specific Antigen Screening Era: Population-Based Estimates for the
• 11329763:Up-Front Tandem High-Dose Chemotherapy Compared With Standard Chemotherapy With Doxorubicin and Paclitaxel in Metastatic Breast Cancer: Resu
• 11329764:Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression Profiling
• 11329765:Model Describing the Relationship Between Pharmacokinetics and Hematologic Toxicity of the Epirubicin-Docetaxel Regimen in Breast Cancer Pat
• 11329766:Malignant Breast Tumors After Radiotherapy for a First Cancer During Childhood
• 11329767:Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B(study 9730)
• 11329768:Statistical Validation of the EORTC Prognostic Model for Malignant Pleural Mesothelioma Based on Three Consecutive Phase II Trials
• 11329769:Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherap
• 11329770:Practical Management of Patients With Non–Small-Cell Lung Cancer Treated With Gefitinib
• 11329771:Wild-Type p53 Overexpression and Its Correlation With MDM2 and p14ARF Alterations: An Alternative Pathway to Non–Small-Cell Lung Cancer
• 11329772:Gemcitabine Plus Carboplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer: A Pha
• 11329773:Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cel
• 11329775:Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy
• 11329776:Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-Trans-Re
• 11329777:Randomized Phase II Evaluation of 6 g/m2 of Ifosfamide Plus Doxorubicin and Granulocyte Colony-Stimulating Factor(G-CSF) Compared With 12 g
• 11329778:Status of Surgical Margins and Prognosis in Adult Soft Tissue Sarcomas of the Extremities: A Series of Patients Treated at a Single Institut
• 11329779:Organ Preservation for Advanced Resectable Cancer of the Base of Tongue and Hypopharynx: A Southwest Oncology Group Trial
• 11329780:Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer:
• 11329781:Detection of Liver Metastases From Endocrine Tumors: A Prospective Comparison of Somatostatin Receptor Scintigraphy, Computed Tomography, an
• 11329782:Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes
• 11329783:Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leuke
• 11329784:Sequencing of Tamoxifen and Radiotherapy After Breast-Conserving Surgery in Early-Stage Breast Cancer
• 11329785:Sequence of Radiotherapy With Tamoxifen in Conservatively Managed Breast Cancer Does Not Affect Local Relapse Rates
• 11329786:Impact of Concurrent Versus Sequential Tamoxifen With Radiation Therapy in Early-Stage Breast Cancer Patients Undergoing Breast Conservation
• 11329787:38000名儿童营养状况分析
• 11329788:1665例社区人群亚健康状况分层分析
• 11329789:曲马多栓肛塞应用于人工流产镇痛100例临床报告
• 11329790:米索前列醇直肠给药预防择期剖宫产出血的临床分析
• 11329791:鼻内镜下咽鼓管吹张术治疗分泌性中耳炎
• 11329792:自体肺移植治疗中心型肺癌(附2例报告)
• 11329793:胸腔镜治疗自发性气胸的麻醉处理
• 11329794:微创穿刺抽吸引流术治疗高血压脑出血
• 11329795:婴幼儿支气管异物41例误诊临床分析
• 11329796:浅谈不典型急性心肌梗死的早期诊断
• 11329797:急性胰腺炎病因变迁(附182例病例报告)
• 11329798:重症急性胰腺炎28例治疗体会
• 11329799:参麦注射液防治血液透析相关性低血压的临床观察
• 11329800:盐酸氨溴索在治疗COPD急性加重期的疗效观察
• 11329801:普米克令舒雾化吸入治疗小儿哮喘的临床疗效观察
• 11329802:善得定和垂体后叶素治疗食管胃底静脉曲张破裂出血对比观察
• 11329803:替米沙坦、福辛普利对原发性高血压患者24 h血压的影响
• 11329804:脑卒中患者继发癫痫的TCD新指标与EEG的对比价值
• 11329805:超声诊断羊膜片1例
• 11329806:经皮穿刺颈椎间盘切吸术的相关问题探讨
• 11329807:宫颈上皮内瘤变与HPV感染的关系
• 11329808:急性期不同性别精神分裂症患者P300的比较研究
• 11329809:小剂量HAE方案治疗难治性白血病的疗效观察
• 11329810:血液透析患者心脏结构和功能改变
• 11329811:肾上腺素在功能性及感染性胃肠疾病所致顽固性腹痛中的作用
• 11329812:超声乳化术治疗白内障的临床应用
• 11329813:预先缝合阻隔切取全厚皮片的方法
• 11329814:5例无痛小肠镜检查护理体会
• 11329815:基因治疗在肌腱愈合中的应用
• 11329816:引发高热惊厥的不良因素及护理对策
• 11329817:人工全髋关节置换术围手术期护理干预
• 11329818:心脏瓣膜置换术后的护理体会
• 11329819:健康教育在功能性鼻内窥镜手术病人中的应用
• 11329820:乳腺癌根治术围手术期的健康教育
• 11329821:对新入院患者实施心理护理体会
• 11329822:联合用药治疗下肢深静脉血栓形成的护理体会
• 11329823:运用PDCA循环提高手术护理记录质量
• 11329824:髋关节结核全髋置换术围手术期护理
• 11329825:胃Dieulafou病2例临床分析
• 11329826:COPD患者院内下呼吸道革兰阴性杆菌分离株的分布及耐病性分析
• 11329827:通气功能及白三烯E4的昼夜节律与夜间支气管 哮喘的相关性研究
• 11329828:Who pays for sex? An analysis of the increasing prevalence of female commercial sex contacts among men in Britain
• 11329829:Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis
• 11329830:Mycoplasma genitalium: prevalence, clinical significance, and transmission
• 11329831:Declining syphilis prevalence among pregnant women in northern Botswana: an encouraging sign for the HIV epidemic?
• 11329833:Syphilis in adults
• 11329834:Testing for Neisseria gonorrhoeae by nucleic acid amplification testing of chlamydia samples using Roche Cobas Amplicor in a rural area in t
• 11329835:Acute bilateral parotitis caused by Mycobacterium scrofulaceum: immune reconstitution disease in a patient with AIDS
• 11329836:Relation of sexual risks and prevention practices with individuals’ stigmatising beliefs towards HIV infected individuals: an exploratory st
• 11329837:Sexual risk behaviour among Surinamese and Antillean migrants travelling to their countries of origin
• 11329838:Audio computer assisted interviewing to measure HIV risk behaviours in a clinic population
• 11329839:Factors associated with HIV testing among black Africans in Britain
• 11329840:Aetiology of sexually transmitted infections and response to syndromic treatment in southwest Uganda
• 11329841:Factors affecting vaginal pH levels among female adolescents attending genitourinary medicine clinics
• 11329842:The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen
• 11329844:Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients
• 11329845:Acceptability of human papillomavirus self testing in female adolescents
• 11329846:Mondor’s disease of penis: a forgotten disease
• 11329847:Risk of HIV/AIDS in China: subpopulations of special importance
• 11329848:HIV in female sex workers in five border provinces of Vietnam
• 11329850:Who reports sexual function problems? Empirical evidence from Britain’s 2000 National Survey of Sexual Attitudes and Lifestyles
• 11329851:Reducing the risk of sexually transmitted infections in genitourinary medicine clinic patients: a systematic review and meta-analysis of beh
• 11329852:HIV-1 seronegativity in a child with proved perinatal HIV infection on HAART
• 11329853:An emerging HIV risk environment: a preliminary epidemiological profile of an MSM POZ Party in New York City
• 11329854:Increase in HIV sexual risk behaviour in homosexual men in Scotland, 1996–2002: prevention failure?
• 11329855:Donovanosis in Australia: going, going...
• 11329856:The attitude of patients towards medical students in a sexual health clinic
• 11329858:The incidence of sexually transmitted infections among frequently screened sex workers in a decriminalised and regulated system in Melbourne
• 11329859:Health indicators among low income women who report a history of sex work: the population based Northern California Young Women’s Survey
• 11329860:Changing the prescribing patterns of sexually transmitted infections in the White Nile Region of Sudan
• 11329862:Improving the quality of STI care by private general practitioners: a South African case study
• 11329864:Blind sampling is superior to anoscope guided sampling for screening for anal intraepithelial neoplasia
• 11329865:The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic ana
• 11329866:STIs and sexual dysfunction
• 11329867:A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR
• 11329868:National survey of diagnostic services for genital herpes
• 11329869:The psychosocial impact of serological herpes simplex type 2 testing in an urban HIV clinic
• 11329870:The epidemiology of genital infection with herpes simplex virus types 1 and 2 in genitourinary medicine attendees in inner London
• 11329871:Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries
• 11329872:Sentinel surveillance of sexually transmitted infections in South Africa: a review
• 11329873:Cardiovascular syphilis in HIV infection: a case-control study at the Institute of Sexually Transmitted Diseases, Chennai, India
• 11329874:How can chlamydia diagnoses increase when their complications are declining?
• 11329875:Chlamydia trachomatis PCR positivity and inflammatory changes on cervical cytology
• 11329876:Complementary therapy and genital warts
• 11329877:Primary HIV infection masquerading as Munchausen’s syndrome
• 11329878:A case of a false positive result on a home HIV test kit obtained on the internet
• 11329879:Progressive neuropsychiatric problems following institution of highly active antiretroviral therapy
• 11329880:Epidemiology of HIV among black and minority ethnic men who have sex with men in England and Wales
• 11329881:Male clients of brothel prostitutes as a bridge for HIV infection between high risk and low risk groups of women in Senegal
• 11329882:Diagnoses of HIV-1 and HIV-2 in England, Wales, and Northern Ireland associated with west Africa
• 11329883:Sex and relationships for HIV positive women since HAART: a quantitative study
• 11329884:Condom effectiveness for prevention of Chlamydia trachomatis infection
• 11329885:Sexual dysfunction in women with HIV
• 11329886:Discordance between trends in chlamydia notifications and hospital admission rates for chlamydia related diseases in New South Wales, Austra
• 11329887:Treatment for syphilis in antenatal care: compliance with the three dose standard treatment regimen
• 11329888:Increasing detection of asymptomatic syphilis in HIV patients
• 11329889:Community based syphilis screening: feasibility, acceptability, and effectiveness in case finding
• 11329890:Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specim
• 11329891:The many faces of sex work
• 11329892:Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future resear
• 11329893:Knowledge of sex partner treatment for past bacterial STI and risk of current STI
• 11329894:HIV infection associated with Strongyloides stercoralis colitis resulting in Streptococcus bovis bacteraemia and meningitis
• 11329895:Modernising sexual health and HIV services in the UK
• 11329896:Sexual behaviour and high risk human papillomavirus infections in Japanese women
• 11329897:Can the promotion of post-exposure prophylaxis following sexual exposure to HIV(PEPSE) cause harm?: Response
• 11329898:Health related quality of life in genital herpes: a pilot comparison of measures
• 11329899:Gender differences in sexual behaviours in response to genitourinary symptoms
• 11329900:Early sexual debut among young men in rural South Africa: heightened vulnerability to sexual risk?
• 11329901:Prevalence and risk factors of chlamydia and gonorrhea among rural Nepali women
• 11329902:Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland
• 11329903:Bacterial vaginosis in relation to menstrual cycle, menstrual protection method, and sexual intercourse in rural Gambian women
• 11329904:Comparison of non-invasive sampling methods for detection of HPV in rural African women
• 11329905:Monitoring STI prevalence using telephone surveys and mailed urine specimens: a pilot test
• 11329906:Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy
• 11329907:Assessing the secular trends in the transmission of HIV in Greece
• 11329908:Can the promotion of post-exposure prophylaxis following sexual exposure to HIV(PEPSE) cause harm?
• 11329909:The changing epidemiology of prevalent diagnosed HIV infections in England, Wales, and Northern Ireland, 1997 to 2003
• 11329910:The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy
• 11329911:Discriminatory attitudes towards people living with HIV/AIDS and associated factors: a population based study in the Chinese general populat
• 11329912:Attitudes to HIV and HIV testing in high prevalence areas of China: informing the introduction of voluntary counselling and testing programm
• 11329913:A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2
• 11329914:Life in the littoral zone: lactobacilli losing the plot
• 11329915:High HIV risk profile among female commercial sex workers in Vinnitsa, Ukraine
• 11329916:Are all genital Chlamydia trachomatis infections pathogenic?
• 11329917:First case of spectinomycin resistant Neisseria gonorrhoeae Isolate in New Delhi, India
• 11329918:Collecting the essence of man: semen collection for HIV transmission studies in sub-Saharan Africa
• 11329919:Foundation training and genitourinary medicine
• 11329920:Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with "illegal social behaviour"
• 11329921:Contraception’s proved potential to fight HIV
• 11329922:Molluscum contagiosum presenting as penile horn in an HIV positive patient
• 11329923:Atypical presentation of lobar nephronia in an adult co-infected with HIV and hepatitis C
• 11329924:Non-disclosure of previously known HIV seropositivity in patients "newly" diagnosed with HIV infection
• 11329925:A video mobile phone and herpes simplex
• 11329926:Clinically resistant trichomoniasis
• 11329927:Female sex workers and fear of stigmatisation
• 11329928:Hepatitis B and C viral infections among STD clinic patients in India
• 11329929:Building a sentinel surveillance system for sexually transmitted infections in Germany, 2003
• 11329930:Lymphogranuloma venereum in the United Kingdom
• 11329931:"We don’t really have cause to discuss these things, they don’t affect us": a collaborative model for developing culturally appropriate sexu
• 11329932:Results of a randomised trial of male condom promotion among Madagascar sex workers
• 11329933:Symptoms of non-gonococcal urethritis in heterosexual men: a case control study
• 11329935:Patient, provider, and clinic characteristics associated with public STD clinic patient satisfaction
• 11329936:Methods employed by genitourinary medicine clinics in the United Kingdom to diagnose bacterial vaginosis
• 11329937:The response to sertraline in men with chronic pelvic pain syndrome
• 11329938:The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an ano
• 11329939:Mexican physicians’ knowledge and attitudes about the human papillomavirus and cervical cancer: a national survey
• 11329940:Early syphilis presenting as a painful polyradiculopathy in an HIV positive individual
• 11329941:Biological and hormonal markers of chlamydia, human papillomavirus, and bacterial vaginosis among adolescents attending genitourinary medici
• 11329942:Whither "chronic prostatitis"?
• 11329943:Incorporating a social networking approach to enhance contact tracing in a heterosexual outbreak of syphilis
• 11329950:Refrigeration does not compromise recovery of Neisseria gonorrhoeae from charcoal transport swabs
• 11329951:STI services in the United Kingdom, how shall we cope?
• 11329952:Determinants of hospital mortality of HIV infected patients from north India
• 11329953:Repeated detection of lymphogranuloma venereum caused by Chlamydia trachomatis L2 in homosexual men in Hamburg
• 11329954:Circumcision practice in the Philippines: community based study R B Lee
• 11329955:Chlamydia trachomatis in female sex workers in Belgium: 1998–2003
• 11329956:Risk of HIV infection among male sex workers in Spain
• 11329958:热带地区重要虫媒传染病的预防与控制
• 11329959:游泳引起的传染病流行及预防
• 11329960:我国弓形虫病核酸疫苗研究概况
• 11329961:Aneurysmal Subarachnoid Hemorrhage
• 11329962:Patent Foramen Ovale and Unexplained Stroke
• 11329963:Inhaled Cyclosporine in Lung Transplantation
• 11329964:Intensive Diabetes Treatment and Cardiovascular Disease
• 11329965:Rotavirus Vaccines
• 11329966:The Charisma of Subgroups and the Subgroups of CHARISMA
• 11329967:Pharmacotherapy for Prehypertension — Mission Accomplished?
• 11329968:Lung Inflammation in ARDS — Friend or Foe?
• 11329969:Case 12-2006 — A 37-Year-Old Man with Hemoptysis and a Pulmonary Infiltrate
• 11329970:Umbilical-Cord Prolapse at 29 Weeks' Gestation
• 11329971:Chronic Musculoskeletal Dysfunction After Massive Weight Loss
• 11329972:Bird-Mite Infestation
• 11329973:Scabies
• 11329974:Interexaminer Reliability of Three Methods of Combining Test Results to Determine Side of Sacral Restriction, Sacral Base Position, and Inno
• 11329975:Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
• 11329976:Oral Ondansetron for Gastroenteritis in a Pediatric Emergency Department
• 11329977:Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker
• 11329978:How to Predict USMLE Scores From COMLEX-USA Scores: A Guide for Directors of ACGME-Accredited Residency Programs
• 11329979:The Challenge of Subgroup Analyses — Reporting without Distorting
• 11329980:A Safety Review of Long-Acting 2-Agonists in Patients With Asthma
• 11329981:The NIH Budget and the Future of Biomedical Research
• 11329982:Osteopathic Medicine in Transition: Postmortem of the Osteopathic Medical Center of Texas
• 11329983:Private Health Care in Canada
• 11329984:Effect of Counterstrain on Stretch Reflexes, Hoffmann Reflexes, and Clinical Outcomes in Subjects With Plantar Fasciitis
• 11329985:Murderous Medicine: Nazi Doctors, Human Experimentation, and Typhus
• 11329986:End-of-Life Decision Making: A Cross-National Study
• 11329987:Stretch Reflex and Hoffmann Reflex Responses to Osteopathic Manipulative Treatment in Subjects With Achilles Tendinitis
• 11329988:A Palliative Ethic of Care: Clinical Wisdom at Life's End
• 11329989:Benign Joint Hypermobility Syndrome: Evaluation, Diagnosis, and Management
• 11329990:High Levels of Industrially Produced Trans Fat in Popular Fast Foods
• 11329991:Interventions Need to Be Consistent With Osteopathic Philosophy
• 11329992:Postmortem Analysis and Retrieval of Implantable Pacemakers and Defibrillators
• 11329993:Postdoctoral Core Competencies in the Predoctoral Curriculum
• 11329994:Curing the Nursing Shortage — The Role of Compensation
• 11329995:Estrogens and Breast Cancer
• 11329996:Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy
• 11329997:Intraperitoneal Chemotherapy for Ovarian Cancer
• 11329998:Computer-Assisted Instruction: A Survey on the Attitudes of Osteopathic Medical Students
• 11329999:Rescue Angioplasty after Thrombolysis
• 11330000:Patient Confidentiality vs Disclosure of Inheritable Risk: A Survey-Based Study

页面最后生成日期：2012/10/30 18:48:00